Cleveland BioLabs
CBLI
#10155
Rank
NZ$86.58 M
Marketcap
NZ$5.59
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Earnings for Cleveland BioLabs (CBLI)

Earnings in 2021 (TTM): -NZ$3.97 Million

According to Cleveland BioLabs 's latest financial reports the company's current earnings are NZ$0.63 Million. In 2020 the company made an earning of -NZ$4.54 Million a decrease over its 2019 earnings that were of -NZ$4.17 Million.

Earnings history for Cleveland BioLabs from 2004 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-NZ$3.97 Million-12.56%
2020-NZ$4.54 Million8.8%
2019-NZ$4.17 Million-50.81%
2018-NZ$8.47 Million-14.3%
2017-NZ$9.89 Million-11.88%
2016-NZ$11.22 Million-50.9%
2015-NZ$22.85 Million-10.24%
2014-NZ$25.45 Million-37.5%
2013-NZ$40.72 Million-23.2%
2012-NZ$53.02 Million19.68%
2011-NZ$44.3 Million133.81%
2010-NZ$18.95 Million68.22%
2009-NZ$11.27 Million-55.51%
2008-NZ$25.32 Million-45.62%
2007-NZ$46.55 Million255.63%
2006-NZ$13.09 Million198.18%
2005-NZ$4.39 Million-1.25%
2004-NZ$4.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$27.85 B-573,529.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$54.92 B-1,130,865.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$16.03 B-330,229.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.51 B-278,331.17%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$16.93 B-348,757.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.66 B-363,812.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-NZ$21.83 Million 349.36%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-NZ$0.29 Billion 5,693.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$32.04 Million 559.60%๐Ÿ‡บ๐Ÿ‡ธ USA